Core 1: Bioethics Shared Resource

核心 1:生物伦理学共享资源

基本信息

  • 批准号:
    10693364
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-30 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY – BIOETHICS SHARED RESOURCE (BESR) (The Bioethics Shared Resource is identical for all three Partnering Institutions) The Bioethics Shared Resource (BESR) is coordinated through the Tuskegee University (TU) Center for Biomedical Research and includes bioethicists consulting for Morehouse School of Medicine (MSM), and the University of Alabama O’Neal Comprehensive Cancer Center at Birmingham (UAB OCCC). The BESR provides exceptional bioethics education, training, guidance, and consultation throughout the MSM/TU/UAB- OCCC Partnership and spearheads research on bioethical issues. BESR activities fall under three overarching and complementary objectives: (1) achieving competencies in content areas of bioethics with a focus on cancer research ethics; (2) integrating bioethics concepts nationally, by presentation of a conference on bioethical issues in cancer research, and throughout the Partnership by dialogue with researchers, clinicians, faculty, students, patient advocates, community health advisors, patient navigators, recruiters, and key personnel; and (3) conducting research to uncover and expand ethical issues from the perspectives of underserved racial/ethnic minorities and making recommendations that inform scientific and behavioral research and policy. The specific aims of the BESR are: (1) To expand on the strategic integration of bioethics in all Partnership projects, at every stage of research, through collaboration with the Research Education and Outreach Cores; (2) To collaborate in teaching graduate/undergraduate courses in bioethics, health disparities and health policy, and bioethics in biosciences, and facilitating discussions of ethical issues in clinical trials through the utilization of the bioethics experts across the three partner institutions; (3) To endow community stakeholders, patient advocates, students, and investigators across all Cores and Projects with tools needed to design, conduct, and manage ethical and culturally sensitive clinical studies through the implementation of an e-Course on Good Clinical Practice (GCP) in social and behavioral cancer research; (4) To facilitate the ethical engagement of study participants in medically underserved urban and rural areas of Alabama and Georgia, addressing issues of trust/mistrust and the informed consent process in clinical and genomic studies; and (5) To leverage the expertise and bioethics facilities at TU, MSM, and the UAB OCCC to conduct projects that address bioethical issues in biomedical, social, and behavioral cancer research involving racial and ethnic minorities. Expansion of these advances to the national level will be via presentation of a conference on ethical issues in cancer research. Appropriate methods for achieving the stated aims are described in the Research Strategy section. Planning and evaluation of outcomes are detailed in the Logic Model.
项目总结-生物伦理学共享资源(BESR) (The生物伦理学共享资源对于所有三个合作机构都是相同的) 生物伦理学共享资源(BESR)通过塔斯基吉大学(TU)中心协调, 生物医学研究,包括为莫尔豪斯医学院(MSM)提供咨询的生物伦理学家,以及 伯明翰亚拉巴马大学奥尼尔综合癌症中心(UAB OCCC)。BESR 提供卓越的生物伦理教育,培训,指导,并在整个MSM/TU/UAB咨询- OCCC伙伴关系,并带头研究生物伦理问题。BESR活动分为三个主要部分 (1)在生物伦理学内容领域取得能力, 癌症研究伦理学;(2)通过举办一次关于 癌症研究中的生物伦理问题,并通过与研究人员,临床医生, 教师,学生,患者倡导者,社区健康顾问,患者导航员,招聘人员和关键 (3)进行研究,从以下角度发现和扩展道德问题: 服务不足的种族/少数民族,并提出建议,告知科学和行为 研究和政策。生物伦理学委员会的具体目标是:(1)扩大生物伦理学的战略整合 在所有伙伴关系项目中,在研究的每个阶段,通过与研究教育和 (2)合作教授生物伦理学、健康差异等研究生/本科生课程 和卫生政策,以及生物科学中的生物伦理学,并促进临床试验中伦理问题的讨论 通过利用三个伙伴机构的生物伦理学专家;(3)使社区 所有核心和项目的利益相关者、患者倡导者、学生和研究者,以及所需的工具, 通过实施一个 社会和行为癌症研究药物临床试验质量管理规范(GCP)电子课程;(4)为了促进伦理 参与亚拉巴马和格鲁吉亚医疗服务不足的城市和农村地区的研究参与者, 解决临床和基因组研究中的信任/不信任问题和知情同意过程;以及(5) 利用TU,MSM和UAB OCCC的专业知识和生物伦理设施开展项目, 解决涉及种族和民族的生物医学、社会和行为癌症研究中的生物伦理问题 少数群体将通过举办一次关于伦理问题的会议, 癌症研究中的问题。实现上述目标的适当方法见研究报告 战略部分。逻辑模型中详细说明了成果的规划和评价。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

REBECCA D PENTZ其他文献

REBECCA D PENTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('REBECCA D PENTZ', 18)}}的其他基金

Patients' Experiences of Emergency Research (PEER)- Views of Patients included in
紧急研究患者的经历 (PEER) - 纳入患者的观点
  • 批准号:
    7864202
  • 财政年份:
    2009
  • 资助金额:
    $ 1.41万
  • 项目类别:
Patients' Experiences of Emergency Research (PEER)- Views of Patients included in
紧急研究患者的经历 (PEER) - 纳入患者的观点
  • 批准号:
    7712208
  • 财政年份:
    2009
  • 资助金额:
    $ 1.41万
  • 项目类别:
Family Decision Making in Pediatric Bone Marrow Transplant
儿科骨髓移植中的家庭决策
  • 批准号:
    7532253
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
Family Decision Making in Pediatric Bone Marrow Transplant
儿科骨髓移植中的家庭决策
  • 批准号:
    7655312
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
Core 1: Bioethics Shared Resource
核心 1:生物伦理学共享资源
  • 批准号:
    10327917
  • 财政年份:
    2005
  • 资助金额:
    $ 1.41万
  • 项目类别:
Research/Innovative Populations/Craft Ethical Guidelines
研究/创新群体/工艺道德准则
  • 批准号:
    6795239
  • 财政年份:
    2004
  • 资助金额:
    $ 1.41万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 1.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了